These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22347503)

  • 1. Kosmotropic anions promote conversion of recombinant prion protein into a PrPSc-like misfolded form.
    Diaz-Espinoza R; Mukherjee A; Soto C
    PLoS One; 2012; 7(2):e31678. PubMed ID: 22347503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The extent of protease resistance of misfolded prion protein is highly dependent on the salt concentration.
    Concha-Marambio L; Diaz-Espinoza R; Soto C
    J Biol Chem; 2014 Jan; 289(5):3073-9. PubMed ID: 24338008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
    Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
    Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro.
    Tange H; Ishibashi D; Nakagaki T; Taguchi Y; Kamatari YO; Ozawa H; Nishida N
    J Biol Chem; 2021; 296():100367. PubMed ID: 33545172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange.
    Smirnovas V; Kim JI; Lu X; Atarashi R; Caughey B; Surewicz WK
    J Biol Chem; 2009 Sep; 284(36):24233-41. PubMed ID: 19596861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seeding specificity and ultrastructural characteristics of infectious recombinant prions.
    Piro JR; Wang F; Walsh DJ; Rees JR; Ma J; Supattapone S
    Biochemistry; 2011 Aug; 50(33):7111-6. PubMed ID: 21776987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
    Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PrP aggregation can be seeded by pre-formed recombinant PrP amyloid fibrils without the replication of infectious prions.
    Barron RM; King D; Jeffrey M; McGovern G; Agarwal S; Gill AC; Piccardo P
    Acta Neuropathol; 2016 Oct; 132(4):611-24. PubMed ID: 27376534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of prions in vitro and the protein-only hypothesis.
    Diaz-Espinoza R; Soto C
    Prion; 2010; 4(2):53-9. PubMed ID: 20448454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
    Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
    Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
    Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.
    Groveman BR; Kraus A; Raymond LD; Dolan MA; Anson KJ; Dorward DW; Caughey B
    J Biol Chem; 2015 Jan; 290(2):1119-28. PubMed ID: 25416779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pH on the human prion protein: insights into the early steps of misfolding.
    van der Kamp MW; Daggett V
    Biophys J; 2010 Oct; 99(7):2289-98. PubMed ID: 20923664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
    Shoup D; Priola SA
    Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopurification of pathological prion protein aggregates.
    Biasini E; Tapella L; Mantovani S; Stravalaci M; Gobbi M; Harris DA; Chiesa R
    PLoS One; 2009 Nov; 4(11):e7816. PubMed ID: 19915706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
    Cobb NJ; Apetri AC; Surewicz WK
    J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.